fashion -WSS

fashion

author：knowledge 2025-09-04 04:26:58 - browse：736

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout LOUD podcast: possible new ALS drug, artificial wombs

WSS

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

FDA panel to weigh approval of NurOwn, controversial ALS drug

Thermo Fisher plant for manufacturing gene therapies to expand

Biotech lab space demand falls sharply

Emergency workers more likely to restrain Black patients: study

EpiPen alternative approval delay highlights citizen petition issue

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lasker Awards 2023: Winners in biomedical research

ChatGPT in medicine: STAT answers readers' burning questions

New chief aims to remake Sanofi Genzyme

Medical records are filled with copy

Drug for rare kidney disease narrowly misses mark in clinical trial

Anesthesiologist group: stop taking Ozempic before surgery

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Listen: BridgeBio's big week & Lilly's Alzheimer's data

knowledge

It's time to take a new tack for treating Alzheimer's

CDC's new outbreak response network to include Northeastern

'The View' co

Biotech stock slump in 2023: awaiting the turnaround

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Hey, doctors: Don't be no

entertainment

knowledge

leisure time

hotspot